Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.

Abstract Histological grading of fibrillary astrocytic neoplasms has proved to be a valuable prognostic tool, but potentially could benefit from more objective data, such as estimates of proliferative rate. The authors have investigated the prognostic utility of quantitative Ki-67 immunoreactivity in a prospective survival analysis of 36 adult patients with astrocytoma, anaplastic astrocytoma, or glioblastoma multiforme diagnosed between 1987 and 1992. A digital image analyzer was used to assay proliferation indices (PIs) in surgical biopsy specimens obtained at first diagnosis (32 of 36) or at a second biopsy of histologically unchanged high-grade disease (4 of 36). A Ki-67 PI of > or = 7.5% was associated with higher histological grade and poorer survival, and the Ki-67 PI was more significantly related to survival (P or = 3% may be at increased risk for shorter survival than those with PI < 3%.

[1]  R. Kiss,et al.  Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors, including astrocytomas, meningiomas, schwannomas, and metastases. , 1993, Human pathology.

[2]  E. Atkinson,et al.  The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain. , 1993, Human pathology.

[3]  Charles B. Wilson,et al.  Proliferative potential of brain tumors. Analyses with Ki‐67 and anti‐dna polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts , 1993, Cancer.

[4]  R. Selker,et al.  Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. , 1992, Surgical neurology.

[5]  P. Hall,et al.  Ki67—Structure, function, and new antibodies , 1992, The Journal of pathology.

[6]  C. Daumas-Duport,et al.  Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases. , 1991, Journal of neurosurgery.

[7]  S. Brem,et al.  The Cycling Pool of Cells within Human Brain Tumors: In Situ Cytokinetics Using the Monoclonal Antibody Ki-67 , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  D. Thomas,et al.  Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling. , 1991, British journal of neurosurgery.

[9]  J. Palmer,et al.  Statistical modelling in analysis of prognosis in glioblastoma multiforme: a study of clinical variables and Ki-67 index. , 1991, British journal of neurosurgery.

[10]  P. Steart,et al.  Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki‐67 study , 1990, Neuropathology and applied neurobiology.

[11]  R. Davis,et al.  Prognostic implications of the proliferative potential of low-grade astrocytomas. , 1988, Journal of neurosurgery.

[12]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[13]  P. Mehraein,et al.  Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. , 1988, Anticancer research.

[14]  M. Hamou,et al.  Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. , 1988, Neurosurgery.

[15]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[16]  P. Kleihues,et al.  The Use of the Monoclonal Antibody Ki-67 in the Identification of Proliferating Cells: Application to Surgical Neuropathology , 1986, The American journal of surgical pathology.

[17]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[18]  P. Burger,et al.  Histologic factors of prognostic significance in the glioblastoma multiforme , 1980, Cancer.